Skip to Content
Get key facts and figures about chronic dry eye

Levocabastine ophthalmic Pregnancy and Breastfeeding Warnings

Levocabastine ophthalmic is also known as: Livostin

Levocabastine ophthalmic Pregnancy Warnings

Levocabastine has been assigned to pregnancy category C by the FDA. Animal studies at doses 16,500 to 66,000 times the maximum recommended human ocular dose have demonstrated teratogenicity. There are no controlled data in human pregnancy. Levocabastine should only be given during pregnancy when benefit outweighs risk.

See references

Levocabastine ophthalmic Breastfeeding Warnings

Levocabastine is excreted into human milk. In one nursing woman, the daily dose in the infant after maternal ophthalmic instillation was approximately 0.5 mcg. Adverse effects in the infant are unlikely.

See references

References for pregnancy information

  1. "Product Information. Livostin (levocabastine)." Ciba Vision Ophthalmics, Duluth, GA.
  2. Dechant KL, Goa KL "Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis." Drugs 41 (1991): 202-24

References for breastfeeding information

  1. Dechant KL, Goa KL "Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis." Drugs 41 (1991): 202-24
  2. "Product Information. Livostin (levocabastine)." Ciba Vision Ophthalmics, Duluth, GA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide